TOP STORIES

• ORGANIZATION JPMA Delays Announcement of Drug Pricing Proposal
  July 27, 2022

• BUSINESS BMS Has High Hopes on Eliquis Follow-Up with Less Bleeding Risks as Patent Loss Looms
  July 26, 2022

• REGULATORY Japan Confirms 1st Monkeypox Case
  July 26, 2022

• COMMENTARY Govt Should Examine Challenges with Emergency Approval Scheme Exposed by Shionogi Pill Review
  July 25, 2022

• REGULATORY KM Biologics’s Smallpox Vaccine Up for Review for Monkeypox Use
  July 25, 2022

• BUSINESS Keytruda, Opdivo, Tagrisso Breach 100 Billion Yen Sales Mark in FY2021: Tally
  July 22, 2022

• BUSINESS Shionogi to Steadily Promote PIII Trial for COVID Pill after Approval Setback
  July 22, 2022

• REGULATORY Japan Again Takes Pass on Emergency Approval for Shionogi’s COVID Pill as Panels Nix Presumed Efficacy
  July 21, 2022

• REGULATORY MHLW Official Sees More “Specified Clinical Research” Data Used in Regulatory Submissions to Fill Industry-Academia Void
  July 20, 2022

• REGULATORY MHLW Eyes Expert Panel Launch This Summer for Drug Distribution and Pricing: Official
  July 19, 2022

• REGULATORY Japan Plans to Lower Minimum Age for Novavax Jab to 12
  July 19, 2022

• ORGANIZATION Savings from Off-Year Drug Re-Pricing Should Go Towards Medical Fees: JMA Chief
  July 15, 2022

• BUSINESS Pfizer Japan Files COVID-19 Vaccine for Ages 6 Months to 4 Years
  July 15, 2022

• REGULATORY Shionogi’s COVID-19 Pill Up for Expert Redeliberation on July 20
  July 14, 2022

• BUSINESS Shionogi’s Four-Day Workweek Not So Popular Yet, but Side Job Plan Gaining Traction
  July 13, 2022

• ORGANIZATION JPMA Think Tank Finds Surge in Japan-Unapproved Drugs in Areas with High Unmet Needs
  July 12, 2022

• REGULATORY After Abe’s Death, Pharma and Medical Circles Fret Shift to Austerity and Tougher Drug Pricing
  July 11, 2022

• BUSINESS As LOEs Loom, Can Mochida Roll Out Authorized Generics for Lexapro and Lialda?
  July 8, 2022

• REGULATORY All Eyes on Scope of Drugs Possibly Designated as Key Resources; Full Discussions after Upper House Poll
  July 7, 2022

• BUSINESS Lecanemab Accepted for US Review, Action Date Set for January: Eisai/Biogen
  July 7, 2022

ページ

• « 先頭
• ‹ Prev
• …
• 64
• 65
• 66
• 67
• 68
• 69
• 70
• 71
• 72
• …
• Next ›
• 最終 »